Early recurrence of hepatitis C virus infection after liver transplantation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Liver transplantation

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.20942PMID 17051560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection

  2007cited by this paper
• C4d in Acute Rejection After Liver Transplantation—A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence

  2006cited by this paper
• Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation

  2006cited by this paper
• HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.

  2006cited by this paper
• Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome

  2006cited by this paper
• Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients.

  2006cited by this paper
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• A Novel Small-Molecule Compound Targeting CCR5 and CXCR3 Prevents Acute and Chronic Allograft Rejection

  2005cited by this paper
• Hepatitis C and liver transplantation

  2005cited by this paper
• Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C

  2005cited by this paper
• Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

  2004cited by this paper
• DR antigens influence graft outcome and HCV recurrence after liver transplantation.

  2004cited by this paper
• Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

  2004cited by this paper
• Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis

  2004cited by this paper
• Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

  2004cited by this paper
• Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation

  2004cited by this paper
• A model to predict severe HCV‐related disease following liver transplantation

  2003influential reference
• The Influence of Viral Genotypes and Rejection Episodes on the Recurrence of Hepatitis C After Liver Transplantation

  2003influential reference
• Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation

  2002cited by this paper
• Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection.

  2002cited by this paper
• Histology predicts cirrhotic evolution of post transplant hepatitis C

  2002cited by this paper
• Cytokines and chemokines in the immune response to hepatitis C infection

  2001cited by this paper
• Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C.

  2000cited by this paper
• Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

  2000cited by this paper
• HCV-related fibrosis progression following liver transplantation: increase in recent years.

  2000influential reference
• High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes

  1999cited by this paper
• Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.

  1999cited by this paper
• Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation.

  1998cited by this paper
• Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen.

  1998cited by this paper
• Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

  1997influential reference
• Banff schema for grading liver allograft rejection: An international consensus document

  1997cited by this paper
• Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.

  1997cited by this paper
• A longitudinal analysis of hepatitis C virus replication following liver transplantation.

  1996cited by this paper
• Histologic progression of recurrent hepatitis C in liver transplant allografts.

  1996cited by this paper
• Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study.

  1994cited by this paper
• The course of hepatitis C virus infection after liver transplantation

  1994cited by this paper

• Role of tissue C4d in differentiation between acute rejection and HCV recurrence after living donor liver transplantation

  2020cites this paper
• Differentiation between Acute Rejection and HCV Recurrence after Living Donor Liver Transplantation: Is there A Role for C4d?

  2017cites this paper
• Immunology of Liver Transplantation

  2016cites this paper
• Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus

  2015cites this paper
• Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

  2014cites this paper
• Comparative analysis of T-cell depletion method for clinical immunotherapy-anti-hepatitis c effects of natural killer cells via interferon-γ production.

  2013cites this paper
• Recurrent diseases following liver transplantation: current concepts

  2012cites this paper
• A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients

  2012cites this paper
• Post-transplant liver biopsy and the immune response: lessons for the clinician

  2012cites this paper
• Chapter 50 – Recurrent Viral Diseases after Liver Transplantation

  2012cites this paper
• Modulation of innate immune responses by hepatitis C virus

  2012cites this paper
• Incidence and Risk Factors of HCV Recurrence after Living Donor Liver Transplantation

  2012cites this paper
• Hepatitis C recurrence after liver transplantation: Has the human leukocyte antigen mismatching at individual loci a role?

  2011cites this paper
• Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3−CD56+ and CD3+CD56+ Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity

  2011cites this paper
• Current views on rejection pathology in liver transplantation

  2010cites this paper
• Nicht-invasive Fibrosegradbestimmung der Leber mittels FibroScan®, APRI und FIB-4-Index bei Lebertransplantierten aufgrund HCV- und äthyltoxischer Zirrhose

  2010cites this paper
• I linfociti T regolatori nella patologia epatica da HCV: dall'epatite cronica al trapianto

  2010influential citation
• EARLY NEW ONSET DISEASES / INJURIES IN THE IN LIVER ALLOGRAFT Preservation and reperfusion injury

  2009cites this paper
• Transplantation pathology.

  2009cites this paper
• Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.

  2009cites this paper
• Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation

  2009cites this paper
• Transplantation Pathology

  2009cites this paper
• Risk Factors for Developing Ischemic‐Type Biliary Lesions After Liver Transplantation

  2009cites this paper
• Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.

  2009cites this paper
• The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity.

  2008cites this paper
• Controversies in liver transplantation for hepatitis C.

  2008cites this paper
• Listing for Liver – Kidney Transplantation in HCV Patients With Prolonged Hepatorenal Syndrome on Hemodialysis

  2008cites this paper
• Liver transplantation: yesterday, today and tomorrow.

  2008cites this paper
• Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus

  2008cites this paper
• Current World Literature

  2007cites this paper
• Acute rejection in HCV‐infected liver transplant recipients: The great conundrum

  2006cites this paper